Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
Select Items

IPO News

03-Oct-2023 (17:36) Valiant Laboratories IPO subscribed 29.75 times
The initial public offer (IPO) of Valiant Laboratories received bids for 22,68,14,490 shares as against 76,23,030 shares on offer, according to stock exchange data at 17:30 IST on Tuesday (3 October 2023). The issue was subscribed 29.75 times.

The issue opened for bidding on Wednesday (27 September 2023) and it will close on Tuesday (3 October 2023). The price band of the IPO is fixed at Rs 133-140 per share. An investor can bid for a minimum of 105 equity shares and in multiples thereof.

The IPO comprises fresh issue of 10,890,000 shares, aggregating to Rs 152.46 crore on upper price band.

The objectives for fresh issue includes investment of Rs 80 crore in wholly-owned subsidiary, Valiant Advanced Sciences, for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals, investment of Rs 15.5 crore in VASPL for funding its working capital requirements and balance amount to be used for general corporate purposes.

The promoters and promoter group hold an aggregate of 3,25,60,000 equity shares, aggregating to 100% of the pre-offer issued and paid-up equity share capital. The post IPO shareholding for the same is expected to be around 74.94%.

Ahead of the IPO, Valiant Laboratories on Tuesday, 26 September 2023, raised Rs 45.73 crore from anchor investors. The board allotted 32.66 lakh shares at Rs 140 each to 4 anchor investors.

Valiant Laboratories is an active pharmaceutical ingredient (API)/Bulk Drug manufacturing company in India having focused on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms and formulations.

The company manufactures a single product, i.e., Paracetamol. The drug is one of the commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). The company manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

The company reported a net profit of Rs 29 crore and net sales of Rs 333.91 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

03-Oct-2023 (17:28) Plaza Wires IPO subscribed 27.78 times
The initial public offer (IPO) of Plaza Wires received bids for 26,37,76,020 shares as against 94,96,114 shares on offer, according to stock exchange data at 17:03 IST on Tuesday (3 October 2023). The issue was subscribed 27.78 times.

The issue opened for bidding on Friday (29 September 2023) and it will close on Thursday (5 October 2023). The price band of the IPO is fixed at Rs 51-54 per share. An investor can bid for a minimum of 277 equity shares and in multiples thereof.

The offer consists of only a fresh issue of 1,32,00,158 equity shares. Of the net proceeds from fresh issue, about Rs 24.413 crore will be used for funding the capital expenditure towards setting up of a new manufacturing unit for house wires, fire resistant wires & cables, aluminium cables, and solar cables to expand product portfolio; Rs 22 crore towards funding working capital requirements and balance is for general corporate purposes.

The company's total borrowing as end of March 2023 stood at Rs 39.675 crore.

Ahead of the IPO, Plaza Wires on Wednesday, 27 September 2023 raised Rs 20 crore from anchor investors. The board allotted 37.04 lakh shares at Rs 54 each to 2 anchor investors.

Plaza Wires is engaged in the business of manufacturing and selling of wires, and selling and marketing of LT aluminum cables and fast-moving electrical goods (FMEG).

The company reported a consolidated net profit of Rs 7.51 crore and net sales of Rs 182.49 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

29-Sep-2023 (17:27) Plaza Wires IPO subscribed 4.68 times
The initial public offer (IPO) of Plaza Wires received bids for 4,44,05,316 shares as against 94,96,114 shares on offer, according to stock exchange data at 17:00 IST on Friday (29 September 2023). The issue was subscribed 4.68 times.

The issue opened for bidding on Friday (29 September 2023) and it will close on Thursday (5 October 2023). The price band of the IPO is fixed at Rs 51-54 per share. An investor can bid for a minimum of 277 equity shares and in multiples thereof.

The offer consists of only a fresh issue of 1,32,00,158 equity shares. Of the net proceeds from fresh issue, about Rs 24.413 crore will be used for funding the capital expenditure towards setting up of a new manufacturing unit for house wires, fire resistant wires & cables, aluminium cables, and solar cables to expand product portfolio; Rs 22 crore towards funding working capital requirements and balance is for general corporate purposes.

The company's total borrowing as end of March 2023 stood at Rs 39.675 crore.

Ahead of the IPO, Plaza Wires on Wednesday, 27 September 2023 raised Rs 20 crore from anchor investors. The board allotted 37.04 lakh shares at Rs 54 each to 2 anchor investors.

Plaza Wires is engaged in the business of manufacturing and selling of wires, and selling and marketing of LT aluminum cables and fast-moving electrical goods (FMEG).

The company reported a consolidated net profit of Rs 7.51 crore and net sales of Rs 182.49 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

29-Sep-2023 (17:21) Valiant Laboratories IPO subscribed 2.17 times

The initial public offer (IPO) of Valiant Laboratories received bids for 1,65,77,925 shares as against 76,23,030 shares on offer, according to stock exchange data at 17:00 IST on Friday (29 September 2023). The issue was subscribed 2.17 times.

The issue opened for bidding on Wednesday (27 September 2023) and it will close on Tuesday (3 October 2023). The price band of the IPO is fixed at Rs 133-140 per share. An investor can bid for a minimum of 105 equity shares and in multiples thereof.

The IPO comprises fresh issue of 10,890,000 shares, aggregating to Rs 152.46 crore on upper price band.

The objectives for fresh issue includes investment of Rs 80 crore in wholly-owned subsidiary, Valiant Advanced Sciences, for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals, investment of Rs 15.5 crore in VASPL for funding its working capital requirements and balance amount to be used for general corporate purposes.

The promoters and promoter group hold an aggregate of 3,25,60,000 equity shares, aggregating to 100% of the pre-offer issued and paid-up equity share capital. The post IPO shareholding for the same is expected to be around 74.94%.

Ahead of the IPO, Valiant Laboratories on Tuesday, 26 September 2023, raised Rs 45.73 crore from anchor investors. The board allotted 32.66 lakh shares at Rs 140 each to 4 anchor investors.

Valiant Laboratories is an active pharmaceutical ingredient (API)/Bulk Drug manufacturing company in India having focused on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms and formulations.

The company manufactures a single product, i.e., Paracetamol. The drug is one of the commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). The company manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

The company reported a net profit of Rs 29 crore and net sales of Rs 333.91 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

28-Sep-2023 (17:09) Valiant Laboratories IPO subscribed 71%
The initial public offer (IPO) of Valiant Laboratories received bids for 54,25,770 shares as against 76,23,030 shares on offer, according to stock exchange data at 17:00 IST on Thursday (28 September 2023). The issue was subscribed 0.71 times.

The issue opened for bidding on Wednesday (27 September 2023) and it will close on Tuesday (3 October 2023). The price band of the IPO is fixed at Rs 133-140 per share. An investor can bid for a minimum of 105 equity shares and in multiples thereof.

The IPO comprises fresh issue of 10,890,000 shares, aggregating to Rs 152.46 crore on upper price band.

The objectives for fresh issue includes investment of Rs 80 crore in wholly-owned subsidiary, Valiant Advanced Sciences, for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals, investment of Rs 15.5 crore in VASPL for funding its working capital requirements and balance amount to be used for general corporate purposes.

The promoters and promoter group hold an aggregate of 3,25,60,000 equity shares, aggregating to 100% of the pre-offer issued and paid-up equity share capital. The post IPO shareholding for the same is expected to be around 74.94%.

Ahead of the IPO, Valiant Laboratories on Tuesday, 26 September 2023, raised Rs 45.73 crore from anchor investors. The board allotted 32.66 lakh shares at Rs 140 each to 4 anchor investors.

Valiant Laboratories is an active pharmaceutical ingredient (API)/Bulk Drug manufacturing company in India having focused on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms and formulations.

The company manufactures a single product, i.e., Paracetamol. The drug is one of the commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). The company manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

The company reported a net profit of Rs 29 crore and net sales of Rs 333.91 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

28-Sep-2023 (15:55) JSW Infrastructure IPO ends with strong subscription

The initial public offer (IPO) of JSW Infrastructure received bids for 5,09,35,27,446 shares as against 13,62,83,186 shares on offer. The issue was subscribed 37.37 times.

The Qualified Institutional Buyers (QIBs) category was subscribed 57.09 times. The Non Institutional Investors (NIIs) category was subscribed 15.99 times. The Retail Individual Investors (RIIs) category was subscribed 10.32 times.

The issue opened for bidding on Monday (25 September 2023) and it closed on Wednesday (27 September 2023). The price band of the IPO is fixed at Rs 113-119 per share.

The offer comprised of only fresh issue of equity share aggregating to Rs 2800 crore. Of the net proceeds of fresh issue, the company will be using Rs 880 crore towards re/pre-payment (in full or part of all/portion) of certain borrowings through investment in wholly owned subsidiaries, JSW Dharmatar Port (JDPPL) and JSW Jaigarh Port (JJPL).

Further, Rs 1029.035 crore will be utilized towards financing capital expenditure requirements through investments in JJPL for proposed expansion/upgradation works i.e. expansion of LPG terminal (Rs 865.751 crore), setting up of electric substation (Rs 59.40 crore) and purchase & installation of dredger (Rs 103.884 crore) at Jaigarh Port; Rs 151.049 crore towards financing capital expenditure requirements through investments in JSW Mangalore Containter Terminal (JMCTPL), a WoS for proposed expansion at Mangalore Container Terminal and balance towards general corporate purposes.

Gross consolidated debt of the company as of end 30 June 2023, was Rs 4,228.387 crore and the net debt was Rs 1,873.778 crore.

Ahead of the IPO, JSW Infrastructure on Friday, 22 September 2023 raised Rs 1,259.99 crore from anchor investors. The board allotted 10.58 crore shares at Rs 119 each to 65 anchor investors.

JSW Infrastructure a part of JSW Group, is the second largest commercial port operator in India in terms of cargo handling capacity. It develops and operates ports and port terminals pursuant to port concessions.

It currently operates nine port concessions in India with an aggregate installed cargo handling capacity of 158.43 MTPA as of 30 June 2023 spread across spread across both west and east coast of India.

The company reported a consolidated net profit of Rs 320.89 crore and net sales of Rs 878.10 crore for the three months ended on 30 June 2023.

Powered by Capital Market - Live News

28-Sep-2023 (11:34) Updater Services IPO ends with 2.90x subscription

The Qualified Institutional Buyers (QIBs) category was subscribed 4.48 times. The Retail Individual Investors (RIIs) category was subscribed 1.39 times. The Non Institutional Investors (NIIs) category was subscribed 0.85 times.

The initial public offer (IPO) of Updater Services received bids for 3,47,45,250 shares as against 1,19,99,999 shares on offer. The issue was subscribed 2.90 times.

The issue opened for bidding on 25 September 2023 and it closed on 27 September 2023. The price band of the IPO was fixed at Rs 280-300 per share.

The offer comprises fresh issue of equities aggregating to Rs 400 crore and offer for sale (OFS) of 80,00,000 equity shares of Rs 10 face value.

On post issue expanded equity, the holding of India Business Excellence Fund II and India Business Excellence Fund IIA will stand reduced to 3.13% and 4.41%, respectively.

Of the net proceeds of fresh issue, the company will be using Rs 133 crore towards re and pre-payment of certain borrowings availed by the company, Rs 115 crore will be used towards funding working capital requirements, Rs 80 crore towards pursuing inorganic initiatives and the balance for general corporate purposes.

Consolidated outstanding borrowings (gross) as end of 31 July 2023, was Rs 194.126 crore.

Ahead of the IPO, Updater Services on 22 September 2023, raised Rs 288 crore from anchor investors. The board allotted 96 lakh shares at Rs 300 each to 18 anchor investors.

Updater Services, a Chennai-based company, is a leading integrated business services platform in India offering integrated facilities management (IFM) services and business support services (BSS) to customers across diverse industries and regions of the country. The company is the second largest player in the IFM market in India and has the widest service offering in the industry.

The company reported a net profit of Rs 35.79 crore and net sales of Rs 2,098.89 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

27-Sep-2023 (17:43) Updater Services IPO subscribed 2.90 times

The initial public offer (IPO) of Updater Services received bids for 3,47,41,450 shares as against 1,19,99,999 shares on offer, according to stock exchange data at 17:36 IST on Wednesday (27 September 2023). The issue was subscribed 2.90 times.

The issue opened for bidding on Monday (25 September 2023) and it will close on Wednesday (27 September 2023). The price band of the IPO is fixed at Rs 280-300 per share. An investor can bid for a minimum of 50 equity shares and in multiples thereof.

The offer comprises fresh issue of equities aggregating to Rs 400 crore and offer for sale (OFS) of 80,00,000 equity shares of Rs 10 face value.

On post issue expanded equity, the holding of India Business Excellence Fund II and India Business Excellence Fund IIA will stand reduced to 3.13% and 4.41%, respectively.

Of the net proceeds of fresh issue, the company will be using Rs 133 crore towards re and pre-payment of certain borrowings availed by the company, Rs 115 crore will be used towards funding working capital requirements, Rs 80 crore towards pursuing inorganic initiatives and the balance for general corporate purposes.

Consolidated outstanding borrowings (gross) as end of 31 July 2023, was Rs 194.126 crore.

Ahead of the IPO, Updater Services on Friday, 22 September 2023, raised Rs 288 crore from anchor investors. The board allotted 96 lakh shares at Rs 300 each to 18 anchor investors.

Updater Services, a Chennai-based company, is a leading integrated business services platform in India offering integrated facilities management (IFM) services and business support services (BSS) to customers across diverse industries and regions of the country. The company is the second largest player in the IFM market in India and has the widest service offering in the industry.

The company reported a net profit of Rs 35.79 crore and net sales of Rs 2,098.89 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

27-Sep-2023 (17:39) JSW Infrastructure IPO subscribed 37.37 times
The initial public offer (IPO) of JSW Infrastructure received bids for 5,09,32,89,432 shares as against 13,62,83,186 shares on offer, according to stock exchange data at 17:30 IST on Wednesday (27 September 2023). The issue was subscribed 37.37 times.

The issue opened for bidding on Monday (25 September 2023) and it will close on Wednesday (27 September 2023). The price band of the IPO is fixed at Rs 113-119 per share. An investor can bid for a minimum of 126 equity shares and in multiples thereof.

The offer comprises of only fresh issue of equity share aggregating to Rs 2800 crore. Of the net proceeds of fresh issue, the company will be using Rs 880 crore towards re/pre-payment (in full or part of all/portion) of certain borrowings through investment in wholly owned subsidiaries, JSW Dharmatar Port (JDPPL) and JSW Jaigarh Port (JJPL).

Further, Rs 1029.035 crore will be utilized towards financing capital expenditure requirements through investments in JJPL for proposed expansion/upgradation works i.e. expansion of LPG terminal (Rs 865.751 crore), setting up of electric substation (Rs 59.40 crore) and purchase & installation of dredger (Rs 103.884 crore) at Jaigarh Port; Rs 151.049 crore towards financing capital expenditure requirements through investments in JSW Mangalore Containter Terminal (JMCTPL), a WoS for proposed expansion at Mangalore Container Terminal and balance towards general corporate purposes.

Gross consolidated debt of the company as of end 30 June 2023, was Rs 4,228.387 crore and the net debt was Rs 1,873.778 crore.

Ahead of the IPO, JSW Infrastructure on Friday, 22 September 2023 raised Rs 1,259.99 crore from anchor investors. The board allotted 10.58 crore shares at Rs 119 each to 65 anchor investors.

JSW Infrastructure a part of JSW Group, is the second largest commercial port operator in India in terms of cargo handling capacity. It develops and operates ports and port terminals pursuant to port concessions.

It currently operates nine port concessions in India with an aggregate installed cargo handling capacity of 158.43 MTPA as of 30 June 2023 spread across spread across both west and east coast of India.

The company reported a consolidated net profit of Rs 320.89 crore and net sales of Rs 878.10 crore for the three months ended on 30 June 2023.

Powered by Capital Market - Live News

27-Sep-2023 (17:17) Valiant Laboratories IPO subscribed 33%

The initial public offer (IPO) of Valiant Laboratories received bids for 24,81,045 shares as against 76,23,030 shares on offer, according to stock exchange data at 17:00 IST on Wednesday (27 September 2023). The issue was subscribed 0.33 times.

The issue opened for bidding on Wednesday (27 September 2023) and it will close on Tuesday (3 October 2023). The price band of the IPO is fixed at Rs 133-140 per share. An investor can bid for a minimum of 105 equity shares and in multiples thereof.

The IPO comprises fresh issue of 10,890,000 shares, aggregating to Rs 152.46 crore on upper price band.

The objectives for fresh issue includes investment of Rs 80 crore in wholly-owned subsidiary, Valiant Advanced Sciences, for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for speciality chemicals, investment of Rs 15.5 crore in VASPL for funding its working capital requirements and balance amount to be used for general corporate purposes.

The promoters and promoter group hold an aggregate of 3,25,60,000 equity shares, aggregating to 100% of the pre-offer issued and paid-up equity share capital. The post IPO shareholding for the same is expected to be around 74.94%.

Ahead of the IPO, Valiant Laboratories on Tuesday, 26 September 2023, raised Rs 45.73 crore from anchor investors. The board allotted 32.66 lakh shares at Rs 140 each to 4 anchor investors.

Valiant Laboratories is an active pharmaceutical ingredient (API)/Bulk Drug manufacturing company in India having focused on manufacturing Paracetamol. Bulk drugs/APIs serve as raw materials for manufacturing finished dosage forms and formulations.

The company manufactures a single product, i.e., Paracetamol. The drug is one of the commonly taken analgesics worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). The company manufactures Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of its customers.

The company reported a net profit of Rs 29 crore and net sales of Rs 333.91 crore for the twelve months ended on 31 March 2023.

Powered by Capital Market - Live News

  • showing 1 to 10 of 100 entries
  • Show
  • entries
 PREVIOUS 123 NEXT  

Follow us:

  • fb icon
  • Twitter icon
  • Linkedin
  • you tube
  • Instagram

Disclaimer:

SMC Global Securities Ltd | CIN : L74899DL1994PLC063609 | Registered Office: 11/6B, Shanti Chamber, Pusa Road, Delhi-110005. | Tel +91-11-30111000 | Compliance Officer: Mr. Ashok Kumar Aggarwal | Tel 011-30111000 Extn. 170 | Email:-aka@smcindiaonline.com| Customer Care Email –smc.care@smcindiaonline.com| Complaint Email –igc@smcindiaonline.com| website: www.smctradeonline.com

SEBI Reg. No. INZ000199438, Member: NSE (07714), BSE (470), MSEI (1002), MCX (8200) & NCDEX (00021). DP SEBI Regn. No. CDSL/NSDL-IN-DP-130-2015, SMC Research Analyst Registration- INH100001849, Mutual Funds Distributor ARN No. 29345. •Insurance services are offered through SMC Insurance Brokers Pvt. Ltd. IRDAI Regn. No: DB 272/04 License No. 289 Valid upto 27/01/2026. • Real Estate Advisory services are offered through SMC Real Estate Advisors Pvt. Ltd.

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. PMS is not offered in commodity derivative segment. Insurance is the subject matter of solicitation. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors. Past performance should not be taken as an indication or guarantee of future performance, and no representation or warranty, express or implied, is made regarding future performance. The price, value of and income from any of the securities or financial instruments mentioned in this report can fall as well as rise.

By submitting your details to SMC, you are authorizing us to send promotional communication through Call/Email/SMS/Whatsapp even though you may be registered under DND.

OUR OTHER WEBSITES Go
IMPORTANT LINKS Go
QUICK LINKS
Go

Toll-free : 1800-11-0909
Email: contact@smctradeonline.com

Sitemap
Plus Minus 
Copyright ©2016 SMC. All Rights Reserved | Disclaimer | Privacy Policy | Copyright| Testimonials| Sitemap| Grievance| design agency: triverse| Powered by C-MOTS Infotech (ISO 9001:2015 certified)

Open my trading account now!  X 

* All fields are compulsory